Antibiotics

Caetano P. Sabino, BSc, PhD Student, explains how photodynamic therapy works.

Recent research shows no clinical benefits from adding azithromycin to standard treatment for adults who presented to emergency departments with acute asthma exacerbations requiring a corticosteroid course.

Researchers from Midwestern University Chicago College of Pharmacy highlight correlations between antibiotic use and horizontal transmission of Vancomycin-resistant Enterococcus (VRE) bacterial species.

Kenneth Mayer, MD, shares some of the common concerns individuals have regarding the use of pre-exposure prophylaxis as protection against HIV.

James S. Lewis, PharmD, FIDSA, explains why antimicrobial susceptibility testing is so important when it comes to stewardship programs.

Jason Pogue, PharmD, BCPS-ID, Clinical Pharmacist, Infectious Diseases, Sinai-Grace Hospital, explains why Pseudomonas aeruginosa is one of the World Health Organization’s critical priority pathogens for new research and development priorities.

Davey Legendre, PharmD, MBA, BCPS, sheds light on the prevalence of confirmed beta-lactam allergies in patients.

Updates to the EML highlight the dangerous growing threat of antimicrobial resistance and the dire situation we are currently facing.

Gonzalo Bearman, MD, MPH, explains when to prescribe antibiotics and suggests to pay attention to the data when it comes to length of treatment.

Superbugs, Zika, antibiotic development, C. difficile, and HIV are the article topics making up this week’s Top 5 articles.

The impact of viruses on community-acquired pneumonia seems to be greater than initially realized and the use of procalcitonin may help distinguish infection type for appropriate treatment.

Contagion® sat down with Rodrigo Mendes, PhD, to discuss research exploring evolving resistance among antibiotics to treat skin infections.

Kirk Hevener, PharmD, PhD, explains the drawbacks of first-line drugs that are currently used to treat C. difficile infections.

The weekly Business Watch includes the latest industry news that practitioners working in infectious diseases need to know.

Thomas File, MD, MSc explains what pleuromutilin antibiotics are and how they work.

Alan Gross, PharmD, BCPS-AQID, explains how antimicrobial stewardship programs need to be strengthened in long-term care facilities.

Incidence of superbug infections are certainly keeping the media in business, but is all the attention translating into an increased awareness of the importance of antibiotic stewardship?

Prof. Josh Davis, MBBS, PhD, discusses the role of combination therapy when it comes to treating invasive Staphylococcus aureus infections.

Niaz Banaei, MD, discusses some reasons why healthcare-associated C. difficile tends to be over-diagnosed.

Researchers describe how government and pharmaceutical companies develop are working to develop new drugs for emerging infectious diseases.

Romney Humphries, PhD, D(ABMM) sat down with Contagion® to discuss the process for receiving clearance on antimicrobial susceptibility tests in the United States.

At the recent ASM Microbe 2017 Conference, Contagion® sat down with David Hooper, MD, ASM Microbe Steering Committee Chair to learn more about his research.

Researchers from the University of Chicago are following the footprints of bacteria throughout a new hospital.

Khalid Eljaaly, PharmD, MS, CAPPS, BCPS, explains why carbapenem antibiotics cause higher rates of C. diff and superinfections.

At the recent ASM Microbe 2017 Conference, Dr. Robert Bonomo shared with attendees highlights of his long-standing career and achievements.